EyePoint, Inc. (EYPT)
13.24
-0.19
(-1.41%)
USD |
NASDAQ |
May 14, 16:00
13.24
0.00 (0.00%)
After-Hours: 20:00
EyePoint EPS Diluted (Quarterly) : -0.9864 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.3954 |
| Merck & Co., Inc. | -1.715 |
| Bristol Myers Squibb Co. | 1.308 |
| Arvinas, Inc. | -0.90 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -84.83M |
| Revenue (Quarterly) | 0.696M |
| Total Expenses (Quarterly) | 85.53M |
| Enterprise Value | 925.76M |
| Gross Profit Margin (Quarterly) | -67.24% |
| Profit Margin (Quarterly) | -12.19K% |
| Earnings Yield | -26.45% |
| Normalized Earnings Yield | -26.45 |